Eulerpool Terminal
The edge that pays for itself.
Current Paradigm Biopharmaceuticals forecasts and price targets in August 2026
Ø Analyst Price Targets
0.66 AUD
+278.86 %
Median
0.66 AUD
+278.86 %
Max
0.68 AUD
Min
0.66 AUD
Last Price
0.17 AUD
Buy
4
Hold
1
Sell
0
The average target price for Paradigm Biopharmaceuticals is 0.66 AUD. (+278.86 % above the current price)
The median price target of Paradigm Biopharmaceuticals is 0.66 AUD.
Stock analysts from many renowned investment banks are closely examining the Paradigm Biopharmaceuticals stock. They conclude their professional Paradigm Biopharmaceuticals stock analyses with a clear recommendation for the Paradigm Biopharmaceuticals stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 4 | 1 | 0 | — |
| 2026-02-01 | 4 | 1 | 0 | 0.66 AUD |
| 2026-02-01 | 4 | 1 | 0 | 0.66 AUD |
| 2026-01-01 | 4 | 1 | 0 | 0.66 AUD |
| 2025-12-01 | 4 | 1 | 0 | 0.66 AUD |
| 2025-12-01 | 4 | 1 | 0 | 0.66 AUD |
Paradigm Biopharmaceuticals Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Paradigm Biopharmaceuticals in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 3.00 M AUD | -40.00 M AUD | -0.10 AUD |
| 2027e | 3.00 M AUD | -40.00 M AUD | -0.10 AUD |
| 2028e | 336.00 M AUD | 85.00 M AUD | 0.22 AUD |